Lung cancer remains the leading cause of cancer-related deaths worldwide, accounting for nearly one in five cancer deaths - around 1.8 million lives lost each year.
OXFORD, England & TORONTO--(BUSINESS WIRE)--Oxford Cancer Analytics (OXcan), the medtech company developing blood tests for early cancer detection using advanced proteomics and AI, today announced it ...
Development and Validation of an Ipsilateral Breast Tumor Recurrence Risk Estimation Tool Incorporating Real-World Data and Evidence From Meta-Analyses: A Retrospective Multicenter Cohort Study Data ...
A new study published in JCO Clinical Cancer Informatics demonstrates that machine learning models incorporating patient-reported outcomes and wearable sensor data can predict which patients with ...
We combined natural language processing and large language models with state-of-the-art machine learning techniques and approaches to treat unbalanced data sets and determine the best solution to ...
New cfDNA test enables multicancer detection with high accuracy, offering a cost effective approach for early diagnosis and screening.
Please provide your email address to receive an email when new articles are posted on . Machine learning models can predict which patients receiving lung cancer therapy may need urgent care visits.
Please provide your email address to receive an email when new articles are posted on . The FDA recently cleared Qure.ai’s qCT LN Quant AI solution for lung nodule management. Early detection, precise ...
MethylScan is a low-cost blood test that detects multiple cancers and liver diseases by analyzing DNA methylation patterns ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results